Serveur d'exploration sur le renard

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Emergency vaccination of rabies under limited resources -- combating or containing?

Identifieur interne : 000257 ( PubMed/Corpus ); précédent : 000256; suivant : 000258

Emergency vaccination of rabies under limited resources -- combating or containing?

Auteurs : Dirk Eisinger ; Hans-Hermann Thulke ; Thomas Selhorst ; Thomas Müller

Source :

RBID : pubmed:15752423

English descriptors

Abstract

Rabies is the most important viral zoonosis from a global perspective. Worldwide efforts to combat the disease by oral vaccination of reservoirs have managed to eradicate wildlife rabies in large areas of central Europe and North-America. Thus, repeated vaccination has been discontinued recently on a geographical scale. However, as rabies has not yet been eradicated globally, a serious risk of re-introduction remains. What is the best spatial design for an emergency vaccination program -- particularly if resources are limited? Either, we treat a circular area around the detected case and run the risk of infected hosts leaving the limited control area, because a sufficient immunisation level has not yet been built up. Or, initially concentrate the SAME resources in order to establish a protective ring which is more distant from the infected local area, and which then holds out against the challenge of the approaching epidemic.

DOI: 10.1186/1471-2334-5-10
PubMed: 15752423

Links to Exploration step

pubmed:15752423

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Emergency vaccination of rabies under limited resources -- combating or containing?</title>
<author>
<name sortKey="Eisinger, Dirk" sort="Eisinger, Dirk" uniqKey="Eisinger D" first="Dirk" last="Eisinger">Dirk Eisinger</name>
<affiliation>
<nlm:affiliation>Department of Ecological Modelling, UFZ-Centre for Environmental Research Leipzig/Halle, Leipzig, Germany. dirk.eisinger@ufz.de</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Thulke, Hans Hermann" sort="Thulke, Hans Hermann" uniqKey="Thulke H" first="Hans-Hermann" last="Thulke">Hans-Hermann Thulke</name>
</author>
<author>
<name sortKey="Selhorst, Thomas" sort="Selhorst, Thomas" uniqKey="Selhorst T" first="Thomas" last="Selhorst">Thomas Selhorst</name>
</author>
<author>
<name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15752423</idno>
<idno type="pmid">15752423</idno>
<idno type="doi">10.1186/1471-2334-5-10</idno>
<idno type="wicri:Area/PubMed/Corpus">000257</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000257</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Emergency vaccination of rabies under limited resources -- combating or containing?</title>
<author>
<name sortKey="Eisinger, Dirk" sort="Eisinger, Dirk" uniqKey="Eisinger D" first="Dirk" last="Eisinger">Dirk Eisinger</name>
<affiliation>
<nlm:affiliation>Department of Ecological Modelling, UFZ-Centre for Environmental Research Leipzig/Halle, Leipzig, Germany. dirk.eisinger@ufz.de</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Thulke, Hans Hermann" sort="Thulke, Hans Hermann" uniqKey="Thulke H" first="Hans-Hermann" last="Thulke">Hans-Hermann Thulke</name>
</author>
<author>
<name sortKey="Selhorst, Thomas" sort="Selhorst, Thomas" uniqKey="Selhorst T" first="Thomas" last="Selhorst">Thomas Selhorst</name>
</author>
<author>
<name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name>
</author>
</analytic>
<series>
<title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Oral</term>
<term>Animals</term>
<term>Computer Simulation</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Disease Outbreaks (veterinary)</term>
<term>Foxes</term>
<term>Models, Biological</term>
<term>Rabies (immunology)</term>
<term>Rabies (prevention & control)</term>
<term>Rabies (veterinary)</term>
<term>Rabies Vaccines (administration & dosage)</term>
<term>Rabies Vaccines (immunology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Rabies Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Rabies</term>
<term>Rabies Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Rabies</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Rabies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Oral</term>
<term>Animals</term>
<term>Computer Simulation</term>
<term>Foxes</term>
<term>Models, Biological</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Rabies is the most important viral zoonosis from a global perspective. Worldwide efforts to combat the disease by oral vaccination of reservoirs have managed to eradicate wildlife rabies in large areas of central Europe and North-America. Thus, repeated vaccination has been discontinued recently on a geographical scale. However, as rabies has not yet been eradicated globally, a serious risk of re-introduction remains. What is the best spatial design for an emergency vaccination program -- particularly if resources are limited? Either, we treat a circular area around the detected case and run the risk of infected hosts leaving the limited control area, because a sufficient immunisation level has not yet been built up. Or, initially concentrate the SAME resources in order to establish a protective ring which is more distant from the infected local area, and which then holds out against the challenge of the approaching epidemic.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15752423</PMID>
<DateCreated>
<Year>2005</Year>
<Month>04</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2006</Year>
<Month>05</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>5</Volume>
<PubDate>
<Year>2005</Year>
<Month>Mar</Month>
<Day>07</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Emergency vaccination of rabies under limited resources -- combating or containing?</ArticleTitle>
<Pagination>
<MedlinePgn>10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rabies is the most important viral zoonosis from a global perspective. Worldwide efforts to combat the disease by oral vaccination of reservoirs have managed to eradicate wildlife rabies in large areas of central Europe and North-America. Thus, repeated vaccination has been discontinued recently on a geographical scale. However, as rabies has not yet been eradicated globally, a serious risk of re-introduction remains. What is the best spatial design for an emergency vaccination program -- particularly if resources are limited? Either, we treat a circular area around the detected case and run the risk of infected hosts leaving the limited control area, because a sufficient immunisation level has not yet been built up. Or, initially concentrate the SAME resources in order to establish a protective ring which is more distant from the infected local area, and which then holds out against the challenge of the approaching epidemic.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We developed a simulation model to contrast the two strategies for emergency vaccination. The spatial-explicit model is based on fox group home-ranges, which facilitates the simulation of rabies spread to larger areas relevant to management. We used individual-based fox groups to follow up the effects of vaccination in a detailed manner. Thus, regionally -- bait distribution orientates itself to standard schemes of oral immunisation programs and locally -- baits are assigned to individual foxes.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Surprisingly, putting the controlled area ring-like around the outbreak does not outperform the circular area of the same size centred on the outbreak. Only during the very first baitings, does the ring area result in fewer breakouts. But then as rabies is eliminated within the circle area, the respective ring area fails, due to the non-controlled inner part. We attempt to take advantage of the initially fewer breakouts beyond the ring when applying a mixed strategy. Therefore, after a certain number of baitings, the area under control was increased for both strategies towards the same larger circular area. The circle-circle strategy still outperforms the ring-circle strategy and analysis of the spatial-temporal disease spread reveals why: improving control efficacy by means of a mixed strategy is impossible in the field, due to the build-up time of population immunity.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">For practical emergency management of a new outbreak of rabies, the ring-like application of oral vaccination is not a favourable strategy at all. Even if initial resources are substantially low and there is a serious risk of rabies cases outside the limited control area, our results suggest circular application instead of ring vaccination.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Eisinger</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Ecological Modelling, UFZ-Centre for Environmental Research Leipzig/Halle, Leipzig, Germany. dirk.eisinger@ufz.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thulke</LastName>
<ForeName>Hans-Hermann</ForeName>
<Initials>HH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Selhorst</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Müller</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2005</Year>
<Month>03</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011819">Rabies Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S660-4</RefSource>
<PMID Version="1">3206077</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prev Vet Med. 2001 Sep 20;51(1-2):95-109</RefSource>
<PMID Version="1">11530197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Onderstepoort J Vet Res. 1993 Dec;60(4):357-63</RefSource>
<PMID Version="1">7777320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schweiz Arch Tierheilkd. 2000 Aug;142(8):423-9</RefSource>
<PMID Version="1">11004890</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc R Soc Lond B Biol Sci. 1986 Nov 22;229(1255):111-50</RefSource>
<PMID Version="1">2880348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Wildl Dis. 2003 Apr;39(2):278-86</RefSource>
<PMID Version="1">12910754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiol Rev. 1980;2:71-96</RefSource>
<PMID Version="1">7000539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prev Vet Med. 1999 Oct 19;47(1-2):1-21</RefSource>
<PMID Version="1">11018731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dtsch Tierarztl Wochenschr. 1997 Nov;104(11):492-5</RefSource>
<PMID Version="1">9471420</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Res. 1996;27(3):255-66</RefSource>
<PMID Version="1">8767887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Wildl Dis. 1998 Jan;34(1):23-32</RefSource>
<PMID Version="1">9476222</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schweiz Med Wochenschr. 1995 May 6;125(18):875-8</RefSource>
<PMID Version="1">7770747</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Biol Sci. 2000 Aug 7;267(1452):1575-82</RefSource>
<PMID Version="1">11007334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Rev Sci Tech. 1993 Mar;12(1):109-13</RefSource>
<PMID Version="1">8518438</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Virus Res. 1977;21:1-36</RefSource>
<PMID Version="1">324250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Infect Dis. 2004 Mar 9;4:9</RefSource>
<PMID Version="1">15113448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Res. 1999 Nov-Dec;30(6):595-605</RefSource>
<PMID Version="1">10596407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Parasitol. 2004 Jan;34(1):37-44</RefSource>
<PMID Version="1">14711588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Vet Med Assoc. 1999 Dec 1;215(11):1612-8</RefSource>
<PMID Version="1">14575027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Vet Med B Infect Dis Vet Public Health. 2003 Dec;50(10):477-83</RefSource>
<PMID Version="1">14720184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>IMA J Math Appl Med Biol. 2001 Mar;18(1):1-23</RefSource>
<PMID Version="1">11339335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Epidemiol Infect. 2001 Dec;127(3):577-87</RefSource>
<PMID Version="1">11811893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 1991 Dec 30;334(1271):459-79</RefSource>
<PMID Version="1">1686115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parassitologia. 1988 Jan-Apr;30(1):53-7</RefSource>
<PMID Version="1">3268773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Virol Suppl. 1997;13:83-94</RefSource>
<PMID Version="1">9413528</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Tierarztl Prax. 1986;14(2):185-96</RefSource>
<PMID Version="1">3738893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Microbiol. 1995 Sep;46(1-3):269-79</RefSource>
<PMID Version="1">8545965</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Rec. 1988 Dec 10;123(24):618-21</RefSource>
<PMID Version="1">3218039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Emerg Infect Dis. 1995 Oct-Dec;1(4):107-14</RefSource>
<PMID Version="1">8903179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Pregl. 1998;51 Suppl 1:9-15</RefSource>
<PMID Version="1">9769649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prev Vet Med. 2003 Jul 30;60(1):91-105</RefSource>
<PMID Version="1">12900151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Anim Behav. 1998 Dec;56(6):1411-1424</RefSource>
<PMID Version="1">9933538</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Biol Sci. 1997 Apr 22;264(1381):495-503</RefSource>
<PMID Version="1">9149424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Comp Immunol Microbiol Infect Dis. 1982;5(1-3):247-56</RefSource>
<PMID Version="1">7128079</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2001 Mar 21;19(17-19):2273-9</RefSource>
<PMID Version="1">11257347</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Zentralbl Veterinarmed B. 1974 Dec;21(10):735-56</RefSource>
<PMID Version="1">4446873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dtsch Tierarztl Wochenschr. 1993 May;100(5):203-7</RefSource>
<PMID Version="1">8319550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Wildl Dis. 2001 Jan;37(1):119-32</RefSource>
<PMID Version="1">11272485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Schweiz Arch Tierheilkd. 2000 Aug;142(8):447-54</RefSource>
<PMID Version="1">11004893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Rec. 1996 Jul 13;139(2):32-5</RefSource>
<PMID Version="1">8839488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Biol Sci. 1998 May 22;265(1399):839-46</RefSource>
<PMID Version="1">9633109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Wildl Dis. 1990 Oct;26(4):486-501</RefSource>
<PMID Version="1">2250325</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005589" MajorTopicYN="Y">Foxes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011818" MajorTopicYN="N">Rabies</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011819" MajorTopicYN="N">Rabies Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC1274270</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2004</Year>
<Month>10</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2005</Year>
<Month>03</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2005</Year>
<Month>3</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>5</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2005</Year>
<Month>3</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15752423</ArticleId>
<ArticleId IdType="pii">1471-2334-5-10</ArticleId>
<ArticleId IdType="doi">10.1186/1471-2334-5-10</ArticleId>
<ArticleId IdType="pmc">PMC1274270</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/RenardV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000257 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000257 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Bois
   |area=    RenardV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:15752423
   |texte=   Emergency vaccination of rabies under limited resources -- combating or containing?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:15752423" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a RenardV1 

Wicri

This area was generated with Dilib version V0.6.27.
Data generation: Tue Mar 28 00:55:51 2017. Site generation: Thu Jan 4 16:57:14 2024